Search for: "Mylan Pharmaceuticals"
Results 421 - 440
of 739
Sorted by Relevance
|
Sort by Date
1 May 2017, 11:59 am
Late last month, pharmaceutical company Mylan announced that its manufacturing partner for the EpiPen Auto-Injector expanded a voluntary recall of certain lots of the EpiPen and EpiPen Jr. product. [read post]
26 May 2007, 11:26 pm
Seasonale had about $35 million in annual sales last year.# Johnson & Johnson's epilepsy drug Topamax, which had $2 billion in 2006 sales, is being challenged by Mylan Laboratories. [read post]
27 Nov 2018, 9:05 am
Impurities found in Mylan’s valsartan API is known as N-nitroso-diethylamine (NDEA), which has been classified as a probable human carcinogen. [read post]
18 Apr 2012, 1:29 pm
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
3 Jun 2015, 9:55 am
In December 2002, when generic manufacturers Teva, Ranbaxy, Mylan and Barr sought permission from the FDA pursuant to the Hatch-Waxman Act to market a generic version of Provigil, Cephalon sued the four companies for patent infringement. [read post]
27 Jul 2011, 4:06 pm
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
5 Sep 2016, 1:10 pm
.* My My Mylan: The Trademark Silver Lining for Mylan's EPIPENMylan has recently come under fire for raising the price of the EPIPEN. [read post]
5 Apr 2012, 1:41 pm
Karst – It was yet another exciting day in the Hatch-Waxman world when news broke Wednesday morning that Teva Pharmaceuticals USA, Inc. [read post]
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
8 Dec 2020, 1:00 pm
[10] Gough, After Nearly 60 Years, Mylan Makes Way for Viatris, Pittsburg Bus. [read post]
13 May 2019, 1:45 pm
(credit: Getty | Fred Dufour) Twenty leading drug companies—including Teva Pharmaceuticals, Pfizer, Novartis, and Mylan—were in cahoots for years to fix and dramatically inflate the prices of more than 100 generic drugs, in some cases to raising prices "well over 1,000 percent," according to a lawsuit filed late last week by 44 states. [read post]
2 Jun 2008, 7:41 pm
In addition to Actavis, the Digitek prescription drug lawsuit also names Mylan Pharmaceuticals Inc. and UDL Laboratories, which distributed the prescrption medication, as defendants. [read post]
14 Nov 2018, 3:25 am
Mylan and Actavis brought separate claims for revocation of the patent in 2014, on the ground that the claims were insufficiently disclosed. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) EU: ‘Victory’ against biopiracy - EPO revokes Schwabe Pharmaceuticals' pelargonium extract patent (Spicy IP) (IP Watch) General Another case for indigenous knowledge protection, but how? [read post]
5 Aug 2011, 12:29 pm
., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
28 Mar 2011, 7:32 am
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011 The Court rejected all attempts by Georgia death row prisoner Troy Davis to further pursue… [read post]
24 Jan 2011, 8:19 pm
., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
